Individual Differences in Drug Response

Clinical trial NCT03809546 · COMPLETED

Trial details

NCT number: NCT03809546
Sponsor: University of Chicago
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Differential Female Response to Δ9-tetrahydrocannabinol (THC)

Start date: 2018-11-06
Primary completion: 2021-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.